It is unclear whether such PDL1 expression in the tumour cells is in part or even mostly a reflection of immune attack via IFN signalling from immune cells (and therefore reflects immunogenicity of the cancer tissue) or conversely whether PDL1 expression might be driven by another pathway in mesothelioma, with only deleterious effects on T-cell responses. This evidence concerns the gene CD274 and mesothelioma.